Cutaneous Adverse Drug Reactions: Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
Fig. 24.1 (a) The hapten-modified peptide is recognized and stimulates T cells. The hapten may also have the ability to activate the innate immune system. (b) The drug binds to…